Zsuzsanna S.
- Country
- Hungary
- Department
- Hematológiai és Őssejt-transzplantációs Osztály
Research Overview
Data & Insights
Has run more than one trial at 4 of 83 partner sites.
Specializations
Hematologic malignancies
Clinical research activity centers on lymphoid and plasma cell disorders, with involvement in therapies for follicular lymphoma, diffuse large B-cell lymphoma, chronic lymphocytic leukemia, multiple myeloma, and Waldenström macroglobulinemia.
- Follicular lymphoma
- Diffuse large B-cell lymphoma
- Multiple myeloma
- Chronic lymphocytic leukemia
Additional interest extends to mantle cell lymphoma, marginal zone lymphoma, lymphoblastic lymphoma, and relapsed or refractory disease across B-cell malignancies.
Plasma cell dyscrasias and amyloidosis
The investigator is engaged in therapeutic studies for AL amyloidosis, light chain amyloidosis, and smoldering multiple myeloma, with a focus on disease control, survival outcomes, and treatment sequencing in plasma cell disorders.
- AL amyloidosis
- Light chain amyloidosis
- Smoldering multiple myeloma
- Relapsed or refractory multiple myeloma
Research involvement also includes myelodysplastic syndrome and myelofibrosis, reflecting a broader interest in marrow failure and clonal hematologic disease.
Autoimmune and inflammatory disorders
Clinical trial participation includes immune-mediated conditions such as Sjögren’s syndrome, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, and ulcerative colitis, with emphasis on systemic disease activity and organ involvement.
- Sjögren’s syndrome
- Systemic lupus erythematosus
- Lupus nephritis
- Ulcerative colitis
Therapeutic interest also covers warm autoimmune hemolytic anemia, primary immune thrombocytopenia, and graft-versus-host disease.
Transplantation and cellular therapy
Work in hematopoietic stem cell transplantation and cellular immunotherapy is evident through studies involving gene-modified T cells, CAR-T therapy, and post-treatment follow-up in hematologic cancers.
- Gene-modified T cells
- CAR-T therapy
- Hematopoietic stem cell transplantation
- Graft-versus-host disease
These interests align with management of transplant-related complications and advanced treatment strategies for refractory blood cancers.
Cardiometabolic, hepatic, and renal disease
The investigator also contributes to trials in heart failure, atherosclerotic cardiovascular disease, chronic hepatitis B, metabolic dysfunction-associated steatohepatitis, and sepsis-associated acute kidney injury.
- Heart failure
- Atherosclerotic cardiovascular disease
- Chronic hepatitis B
- Sepsis-associated acute kidney injury
Additional therapeutic areas include lipid disorders, obesity, and renal cell carcinoma.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.